Feed CLPBY
CL

Coloplast A/S

CLPBY · OTC

$6.26 -0.96% (-$0.06)
1M -14.19%
Market Cap 93.7B kr
P/E Ratio 34.01x
Div. Yield 5.77%
ROE 19.63%

Bulios Fair Price

$8.72

39.3% upside

Current Price

$6.26

Undervalued Fair Value Overvalued

According to Bulios Fair Price, CLPBY is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
6/9
Valuation
57 /100
Fair
P/B 7.01x
P/S 3.46x
P/E 34.01x
Growth
40 /100
Stable
Book val. growth 24.89%
FCF growth 8.26%
EPS growth 11.73%
Profitability
93 /100
Strong
FCF margin 23.34%
Op. margin 27.81%
Gross margin 64.75%
Quality
83 /100
Excellent
Asset turnover 0.58x
ROA 5.87%
ROIC 59.76%
Debt
61 /100
Moderate
Net debt/EBITDA 1.91x
Int. coverage 10.94x
Debt/Equity 1.78x
Stability
93 /100
Stable
Profitable years 6
EPS volatility 19.26%
Beta 0.53x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CLPBY
Online

About the company

Coloplast A/S is a Danish healthcare company headquartered in Humlebæk that specializes in the development and manufacture of healthcare products, particularly in the areas of urology, dermatology, and ostomy care. Founded in 1957, Coloplast is now one of the leading global suppliers of medical products that aim to improve the quality of life for patients with various health conditions. The company focuses on innovation and research, developing products such as ostomy appliances, catheters, and wound care solutions designed to be as comfortable and effective as possible for users.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Gavin Wood

Employees

16,907

Headquarters

Humlebæk

Upcoming events

03 NOV

Earnings

Upcoming earnings report

32d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.